Devatal

DevaTal Inc. was established in 2003 to exploit proprietary technologies for the production of recombinant proteins and monoclonal antibodies. The company utilizes colloidal gold and fluorescence detection techniques to develop rapid diagnostic tests for infectious diseases and other analytes.

美国Devatal   www.devatal.com
美国Devatal公司成立于2003年，以开发专有技术生产的重组蛋白和单克隆抗体为主。公司利用胶体金及荧光检测技术为传染病和其他检测分析开发快速诊断测试。

Devatal公司的专业知识和技术重点在以下领域： 开发与艾滋病病毒、人体T细胞白血病病毒、肝炎相应的优质重组蛋白以及其他相关的蛋白；开发快速、简便的诊断试验；为研究和诊断领域开发单克隆抗体及其他免疫试剂。

DevaTal manufactures biological products for basic research, clinical research, and clinical diagnostic markets. Our biological reagents are used in life science research, for immunological detection of infectious diseases and other analytes. We produce recombinant proteins, monoclonal antibodies, and other research reagents.

DevaTal focuses its expertise and technology to produce a wide range of Cytokines, Growth Factors, Chemokines, Hormones, Enzymes, Viral Antigens, Monoclonal antibodies, and many other Recombinant Proteins. This includes the development and marketing of superior recombinant proteins corresponding to HIV, HTLV, hepatitis, other viral proteins, and other immuno-reagents required for Research and Diagnostic purposes.

The company uses both direct and indirect sales through strategic alliances in various market segments. DevaTal has R&D contracts with key Biopharmaceutical and diagnostic corporations in both the USA and offshore. We provide the technology and know-how for the production of large-scale production of Recombinant Proteins. These relationships are based on OEM, royalties, and profit sharing agreements.